Sep 28, 2026 08:02AM
Sep 28, 2026 08:00AM
Sep 24, 2026 08:02AM
Sep 24, 2026 08:00AM
Aug 4, 2025 08:03AM
Aug 4, 2025 08:00AM
Apr 14, 2025 08:00AM Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
Mar 7, 2025 04:45PM
Dec 18, 2024 12:05PM
Dec 18, 2024 08:00AM
Nov 6, 2024 04:30PM
Oct 24, 2024 10:50AM
Oct 7, 2024 08:00AM
Sep 25, 2024 08:03AM Ainos (AIMD) Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial
Sep 25, 2024 08:00AM
Sep 23, 2024 08:09AM
Sep 20, 2024 08:00AM
Sep 17, 2024 08:09AM
Sep 17, 2024 08:00AM
Aug 5, 2024 04:15PM
May 13, 2024 04:10PM Ainos Reports First Quarter 2024 Financial Results
Mar 8, 2024 04:20PM
Feb 5, 2024 09:05AM
Feb 5, 2024 09:00AM
Nov 28, 2023 08:30AM
Nov 21, 2023 08:32AM
Nov 21, 2023 08:30AM
Nov 9, 2023 04:30PM Ainos Reports Third Quarter 2023 Financial Results
Sep 19, 2023 12:26PM
Sep 18, 2023 07:03AM
Sep 18, 2023 07:00AM
Nov 7, 2022 07:30AM
Nov 3, 2022 07:00AM
Oct 31, 2022 07:00AM
Sep 30, 2022 07:02AM Ainos (AIMD) Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron
Sep 30, 2022 07:00AM
Aug 24, 2022 07:02AM
Aug 24, 2022 07:00AM
Aug 17, 2022 08:05AM
Aug 15, 2022 07:20AM
Aug 11, 2022 02:12PM
Jun 27, 2022 07:00AM Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19

335,055 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All